Volatility is likely to remain elevated amid ongoing uncertainty about U.S. trade policy and bilateral tariff negotiations.

From an ETF provider’s perspective, creating new ETFs with different risk/reward profiles solves two problems. It’s a new ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

GDX offers access to diversified, liquid exposure to senior gold miners. Investors who are looking to get precious metals ...

Find out why major financial players are betting on "Y'all Street" to challenge the NYSE and Nasdaq and what it means for ...

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak ...

Jackson National Life Insurance Company® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Market Link Pro® III (JMLPIII) and Jackson Market Link ...

In the past Mr. Hachigian was Chairman at JELD-WEN Holding, Inc. and Non-Executive Chairman of JELD-WEN, Inc. (a subsidiary of JELD-WEN Holding, Inc.), Principal at Skykarr Capital LLC, Chairman & ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool ...

NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / On May 12, 2025, Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) ("Apimeds" or the "Company"), a clinical stage biopharmaceutical company that is in t ...